DIMENSIONAL FUND ADVISORS LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$6,011,000
+110.4%
88,277
-1.3%
0.00%
+100.0%
Q2 2022$2,857,000
-84.5%
89,414
-83.2%
0.00%
-83.3%
Q1 2022$18,384,000
+49.7%
530,693
+26.5%
0.01%
+50.0%
Q4 2021$12,282,000
+42.4%
419,563
+23.9%
0.00%
+33.3%
Q3 2021$8,626,000
-38.5%
338,507
-15.5%
0.00%
-25.0%
Q2 2021$14,028,000
-8.8%
400,652
+6.1%
0.00%
-20.0%
Q1 2021$15,383,000
-13.4%
377,506
-8.0%
0.01%
-16.7%
Q4 2020$17,763,000
-29.3%
410,118
-10.0%
0.01%
-45.5%
Q3 2020$25,110,000
-14.5%
455,437
-2.0%
0.01%
-15.4%
Q2 2020$29,358,000
+19.0%
464,928
-3.7%
0.01%0.0%
Q1 2020$24,670,000
-36.7%
482,863
-1.6%
0.01%
-7.1%
Q4 2019$38,988,000
+78.8%
490,492
+9.1%
0.01%
+75.0%
Q3 2019$21,807,000
-6.0%
449,416
+1.9%
0.01%
-11.1%
Q2 2019$23,202,000
-9.0%
441,083
-8.5%
0.01%
-10.0%
Q1 2019$25,505,000
+26.2%
481,869
-2.1%
0.01%
+11.1%
Q4 2018$20,214,000
+545.0%
492,420
+497.0%
0.01%
+800.0%
Q3 2018$3,134,00082,4860.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Grace Capital 177,414$14,103,00011.50%
Fernwood Investment Management, LLC 258,012$20,509,0009.81%
Perceptive Advisors 5,865,726$466,266,0009.26%
ArchPoint Investors 186,756$14,845,0004.54%
STANSBERRY ASSET MANAGEMENT, LLC 115,638$9,192,0003.74%
Camber Capital Management LP 730,000$58,028,0002.95%
Profit Investment Management, LLC 46,873$3,726,0002.50%
Casdin Capital, LLC 300,000$23,847,0002.19%
SECTORAL ASSET MANAGEMENT INC 174,594$13,878,0002.07%
Corriente Advisors, LLC 40,000$3,180,0001.71%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders